AM-4030

Identifiers
IUPAC name (6S,6aR,9R,10aR)-9-(hydroxymethyl)-6--6-methyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzochromen-1-ol
CAS Number	587023-54-9 Y
PubChem CID	10550598
ChemSpider	8725989 Y
UNII	CGYGFRRXKK
CompTox Dashboard (EPA)	DTXSID001027481
Chemical and physical data
Formula	C27H42O4
Molar mass	430.629 g·mol−1
3D model (JSmol)	Interactive image
SMILES OCC=CC3(C)C1CCC(CO)CC1c2c(O3)cc(cc2O)C(C)(C)CCCCCC
InChI InChI=1S/C27H42O4/c1-5-6-7-8-12-26(2,3)20-16-23(30)25-21-15-19(18-29)10-11-22(21)27(4,13-9-14-28)31-24(25)17-20/h9,13,16-17,19,21-22,28-30H,5-8,10-12,14-15,18H2,1-4H3/b13-9+/t19-,21-,22-,27+/m1/s1 Y Key:SYKOWCSKDYZBIL-BKTWVJDESA-N Y
(verify)

AM-4030 is an analgesic drug which is a cannabinoid receptor agonist. It is a derivative of HU-210 which has been substituted with a 6β-((E)-3-hydroxyprop-1-enyl) group. This adds a "southern" aliphatic hydroxyl group to the molecule as seen in the CP-series of nonclassical cannabinoid drugs, and so AM-4030 represents a hybrid structure between the classical and nonclassical cannabinoid families,^[1] with the 6-hydroxyalkyl chain rigidified with a double bond with defined stereochemistry. This gives AM-4030 a greater degree of selectivity, so while it is still a potent agonist at both CB₁ and CB₂, it is reasonably selective for CB₁, with a K_i of 0.7nM at CB₁ and 8.6nM at CB₂, a selectivity of around 12x.^[2][3] Resolution of the enantiomers of AM-4030 yields an even more potent compound, although with less selectivity, with the (−) enantiomer AM-4030a having a K_i of 0.6nM at CB₁ and 1.1nM at CB₂.^[4]

See also

• AM-919
• AM-938

References